To include your compound in the COVID-19 Resource Center, submit it here.

Humira adalimumab regulatory update

The U.K.'s National Institute for Health and Clinical Excellence (NICE) recommended that TNF alpha inhibitors Humira adalimumab from ABT and partner Eisai and

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE